NCT05633602 2025-05-28
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
SWOG Cancer Research Network
Phase 3 Active not recruiting
SWOG Cancer Research Network
Eastern Cooperative Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC
SWOG Cancer Research Network
ETOP IBCSG Partners Foundation
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC